Lipoprotein Subfractions Highly Associated With Renal Damage in Familial Lecithin:Cholesterol Acyltransferase Deficiency

Amelioration of circulating lipoprotein profile and proteinuria in a patient with LCAT deficiency due to a novel mutation (Cys74Tyr) in the lid region of LCAT under a fat-restricted diet and ARB treatment

(2013) Shokichi Naito et al.   ATHEROSCLEROSIS

Proteinuria in early childhood due to familial LCAT deficiency caused by loss of a disulfide bond in lecithin:cholesterol acyl transferase

(2011) A.G. Holleboom et al.   ATHEROSCLEROSIS

High prevalence of mutations in LCAT in patients with low HDL cholesterol levels in the Netherlands: Identification and characterization of eight novel mutations

(2011) Adriaan G. Holleboom et al.   HUMAN MUTATION

Molecular Analysis of a Novel LCAT Mutation (Gly179 → Arg) Found in a Patient with Complete LCAT Deficiency

(2011) Xiao Li Wang et al.   Journal of Atherosclerosis and Thrombosis

AAV8-Mediated Long-Term Expression of Human LCAT Significantly Improves Lipid Profiles in hCETP;Ldlr+/− Mice

(2011) Zhu Chen et al.   Journal of Cardiovascular Translational Research

Adipocytes as a vehicle for ex vivo gene therapy: Novel replacement therapy for diabetes and other metabolic diseases

(2011) Masayuki Kuroda et al.   Journal of Diabetes Investigation

Effect of Recombinant Human Lecithin Cholesterol Acyltransferase Infusion on Lipoprotein Metabolism in Mice

(2010) X. Rousset et al.   JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS

Disturbed apolipoprotein A-I-containing lipoproteins in fish-eye disease are improved by the lecithin:cholesterol acyltransferase produced by gene-transduced adipocytes in vitro

(2010) Sakiyo Asada et al.   MOLECULAR GENETICS AND METABOLISM

Changes in lipoprotein profile and urinary albumin excretion in familial LCAT deficiency with lipid lowering therapy

(2009) Michael S. Yee et al.   ATHEROSCLEROSIS